Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; (b) 1000-count Bottle, NDC 68462-390-10: RX Only, Manufactured for: Glenmark, Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India,
Published November 29, 2023 · Recall initiated: October 23, 2023
Summary
FDA records drug Class III recall D-0112-2024, published November 29, 2023 and initiated October 23, 2023. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Terminated; Reported quantity: 8,448 30-count bottles, 168 1000-count bottles; Lot: Lot # 17220002, Exp Date 11/30/2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25®C/60% RH).
What to do
Voluntary: Firm initiated · Letter
Get an email if ESOMEPRAZOLE MAGNESIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ESOMEPRAZOLE MAGNESIUM
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Distributor
- Nationwide in the USA
- UPC
- 0368462391303
- Lot
- Lot # 17220002, Exp Date 11/30/2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEsomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, RxMay 28, 2025
- FDAEsomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, RxMay 28, 2025
- FDAEsomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only,December 11, 2024
- FDAIntegrity Biochem HSC 70-VA, Alcohol Antiseptic 70%, Hand Sanitizer, Vanilla Scented Topical Gel 208.19L (55November 29, 2023
- FDABuspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-countNovember 29, 2023
- FDAEsomeprazole Magnesium Delayed-Release Capsules, USP, 40mg, Rx Only, 90 Capsules per bottle, Manufactured by:October 5, 2022
Questions about this recall
Was Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; (b) 1000-count Bottle, NDC 68462-390-10: RX Only, Manufactured for: Glenmark, Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, recalled?
Yes. FDA published recall D-0112-2024 on November 29, 2023. Reported hazard: Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25®C/60% RH).
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ESOMEPRAZOLE MAGNESIUM. UPC: 0368462391303.